Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UAE FIBROID Registry Unlikely To Deliver Conclusive Post-Op Fertility Data

This article was originally published in The Gray Sheet

Executive Summary

Insufficient data from the uterine artery embolization FIBROID registry will necessitate further investigation to assess the impact of the procedure on fertility and future pregnancies, according to James Spies, MD, Georgetown University Medical Center

You may also be interested in...



UAE FIBROID Results Show Improvement, No Device Differences

Initial results of patients treated with uterine artery embolization (UAE) in the FIBROID registry show significant improvements in symptoms and quality of life, but reveal no differences in outcome among the various device brands studied

UAE FIBROID Results Show Improvement, No Device Differences

Initial results of patients treated with uterine artery embolization (UAE) in the FIBROID registry show significant improvements in symptoms and quality of life, but reveal no differences in outcome among the various device brands studied

Cytyc Targets Women “Suffering In Silence” From Widespread Menorrhagia

Cytyc is relying on women's health groups to drive awareness of abnormal uterine bleeding in women who have not yet sought treatment

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021925

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel